Top Abstract Purchase Related
Home
>
Node
>
Subnode

Adverse effects of hormone preparations and related medications used to treat disorders of bone and mineral metabolism

Hoppe, B.; Alon, U.S.

Pediatric Endocrinology Reviews Per 2(Suppl 1): 146-152

2004

ISSN/ISBN: 1565-4753
PMID: 16456493
Document Number: 566985
Disorders of bone and mineral metabolism can be effectively treated by a relatively small number of preparations which include minerals, vitamin D metabolites, other hormones, bisphosphonates, and diuretics. In addition to achieving the treatment goals, management of these patients must include close monitoring for potential adverse effects of the medications. The following chapter addresses the currently available treatment modalities of bone and mineral disorders and their potential side effects. Careful attention to recommended precautions, means of monitoring for potential adverse effects, and consequent adjustment of therapy play a key role in protecting the patient from development of serious adverse effects.

Document emailed within 1 workday
Secure & encrypted payments

Frame, B.; Marel, G.M. 1983: Clinical disorders of bone and mineral metabolism Annals of Internal Medicine 99(5): 725-727
Chang, B.; Yang, J.; Li, H.; Lu, S.; Chen, L.; Fang, P. 2011: Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats Die Pharmazie 66(7): 535-537
Hamada, Y.; Fukagawa, M. 2008: Relationship between lipid and glucose metabolism and bone mineral metabolism : pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia Clinical Calcium 18(5): 671-676
Zheng, S.; Wu, Y.; Zhang, Z.; Yang, X.; Hui, Y.; Zhang, Y.; Chen, S.; Deng, W.; Liu, H.; Ekangaki, A.; Stocks, J.; Harper, K.; Liu, J. 2003: Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in postmenopausal women: a randomized clinical trial in Beijing Chinese Medical Journal 116(8): 1127-1133
Morukov, B.V.; Zaĭchik, V.E.; Ivanov, V.M.; Orlov, O.I. 1987: Use of diphosphonates for correcting disorders of calcium metabolism and mineral composition of bone tissue in 60-day hypokinesia in rats Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1987(2): 75-77
Schneider, D.L.; Barrett-Connor, E.L.; Morton, D.J. 1994: Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen JAMA 271(16): 1245-1249
Katz, I.A.; Takizawa, M.; Jaffe, I.I.; Stein, B.; Fallon, M.D.; Epstein, S. 1991: Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. a pilot study Transplantation 52(3): 571-574
Schmidt, U.J.; Lindenhayn, K.; Nelius, D.; Mühlbach, R.; Hähnel, H.; Kalbe, I. 1973: Adverse effects of long-term glucocorticoid therapy on bone metabolism Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(8): 119-122
Bagheri, S.C.; Mehrabi, M.; Khan, H.A.; Kademani, D. 2007: Overdose, adverse effects, and safety of oral medications Journal of the California Dental Association 35(8): 565-572
Zhuravskiĭ, N.I.; Gulyĭ, M.F.; Mel'nichuk, D.A.; Bratus', N.I.; Liubetskaia, T.V. 1986: Effect of the mineral-ammonia preparations MP-15 and MP-7 on nitrogen metabolism in cows Ukrainskii Biokhimicheskii Zhurnal 58(5): 83-86
Sugino, K.; Kure, Y.; Suzuki, A.; Sekino, H.; Iwasaki, H.; Goto, H.; Matsumoto, A. 1990: Bone metabolism in thyroidectomized patients--evaluation of bone mineral content by quantitative CT Nihon Geka Gakkai Zasshi 91(4): 500-507
Ghosh, A.K. 2001: Communications of adverse effects of medications: physician challenges and informatics readiness Archives of Internal Medicine 161(19): 2387
Kopaliani, M.G.; Kilasonia, L.O. 2005: Biochemical markers of bone metabolism and cortical bone mineral density in young healthy females Georgian Medical News 120: 58-61
Palomba, S.; Orio, F.; Morelli, M.; Russo, T.; Pellicano, M.; Nappi, C.; Mastrantonio, P.; Lombardi, G.; Colao, A.; Zullo, F. 2002: Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism Journal of Clinical Endocrinology and Metabolism 87(10): 4476-4481
Ureña, P. 2008: Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure Nephrologie and Therapeutique 4 Spec no 1: 9
Fajreldines, A.; Schnitzler, E.; Insua, J.T.; Valerio, M.; Davide, L.; Pellizzari, M. 2018: Reduction of inappropriate prescriptions and adverse effects to medications in hospitalized elderly patients Medicina 78(1): 11-17
Krawczyk, J.; Głyda, A.; Warenik-Szymankiewicz, A.; Meczakalski, B. 1999: The assessment of selected markers of bone tissue metabolism and bone mineral density in girls with resulting from forced weight reduction Ginekologia Polska 70(5): 401-406
Vania Padillavazquez, A.; Lamadridfigueroa, H.; Cruzvaldez, A. 2007: El peso, el porcentaje de grasa y la densidad minéral ósea materna son determinantes de la densidad minéral ósea en mujeres adolescentes y adultas jóvenes - Weight, fat percentage and maternal bone mineral density are determinants of bone mineral density in adolescent and young adult females Boletin Medico del Hospital Infantil de Mexico (Ed. Espanola) 64(2): 72-82
Lange, U.; Boss, B.; Teichmann, J.; Stracke, H.; Neeck, G. 2000: Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy Zeitschrift für Rheumatologie 59(Suppl 2): Ii/137-Ii/141
Eiken, P.A. 1997: The effect of hormone replacement therapy on bone mineral content and on fractures Ugeskrift for Laeger 159(5): 570-576